产品编号 T64167Cas号 1227948-82-4 别名IN-10018, BI-853520 Ifebemtinib (BI-853520) 是一种具有口服活性和强效性的粘附斑激酶 (FAK) 抑制剂 (IC50=1 nM),具有抗肿瘤活性,可抑制恶性胸膜间皮瘤中的球状体形成和原位肿瘤生长,可用于研究乳腺癌和卵巢癌。
BI-853520 CAS No. : 1227948-82-4 MCE 站:BI-853520 产品活性:BI 853520 (IN-10018) 是一种具有口服活性的粘附斑激酶 (FAK) 强效抑制剂 (重组 FAK IC50=1nM),BI 853520 表现出对癌细胞的抗增殖活性。 研究领域:Protein Tyrosine Kinase/RTK 作用靶点:FAK In Vitro: BI 853520 (0-3 μM; 2 h) ...
Ifebemtinib (BI-853520) is an adhesion plaque kinase inhibitor with anti-tumour activity for the study of breast cancer.
Synonyms:BI-853520;BI-853520 (BI 853520 CAS: MF: MW:0 EINECS: Mol File:Mol File Information Error Report Your Email: Browse by NationalityBI-853520SuppliersChina suppliers BI-853520RecommendSuppliers Recommend You Select Member Companies.
ChemicalBook provide Chemical industry users with BI-853520 Boiling point Melting point,BI-853520 Density MSDS Formula Use,If You also need to BI-853520 Other information,welcome to contact us.
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that regulates a plethora of downstream signaling pathways essential for cell migration, proliferation and death, processes that are exploited by cancer cells during malignant progression. Thes
摘要: The present invention relates to a use of BI853520 or a pharmaceutically acceptable salt thereof in preparing drugs for treating tumors in combination with chemotherapeutic drugs. 二、法律状态 暂无信息 三、权利要求 暂无信息 四、说明书暂无信息 打开APP,查看更多专利的权利要求、说明书更多...